Back to top
Read MoreHide Full Article
  • Shares of GlycoMimetics, Inc. (GLYC - Free Report) surged 14.9% after the company reported positive results from Phase 1/2 trial for its GMI-1271
  • KMG Chemicals, Inc.’s (KMG - Free Report) shares rallied 14.8% after reporting first quarter 2018 earnings of $0.83 a share, surpassing the Zacks Consensus Estimate of $0.63
  • Shares of VeriFone Systems, Inc. (PAY - Free Report) gained 1.5% after reporting fourth quarter 2017 revenues of $477 million, surpassing the Zacks Consensus Estimate of $472 million
  • Peregrine Pharmaceuticals, Inc.’s shares tanked 17.7% after posting second quarter 2018 earnings per share of $0.13, below the Zacks Consensus Estimate of $0.14



In-Depth Zacks Research for the Tickers Above


Normally $25 each - click below to receive one report FREE:


Verifone Systems, Inc. (PAY) - free report >>

KMG Chemicals, Inc. (KMG) - free report >>

GlycoMimetics, Inc. (GLYC) - free report >>


More from Zacks Corporate Summary

You May Like